Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management
Unprecedented advances in our understanding of the pathobiology, prognostication, and
therapeutic options in mantle cell lymphoma (MCL) have taken place in the last few years …
therapeutic options in mantle cell lymphoma (MCL) have taken place in the last few years …
[HTML][HTML] A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas
Several editions of the World Health Organization (WHO) classifications of lympho-
hemopoietic neoplasms in 2001, 2008 and 2017 served as the international standard for …
hemopoietic neoplasms in 2001, 2008 and 2017 served as the international standard for …
The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee
Since the publication of the Revised European-American Classification of Lymphoid
Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have …
Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have …
Mantle cell lymphoma in 2022—A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments
P Jain, ML Wang - American journal of hematology, 2022 - Wiley Online Library
The field of mantle cell lymphoma (MCL) has witnessed remarkable progress due to
relentless advances in molecular pathogenesis, prognostication, and newer treatments …
relentless advances in molecular pathogenesis, prognostication, and newer treatments …
OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF TUMORS OF THE HEMATOPOIETIC AND LYMPHOID TISSUES
This manuscript represents a review of lymphoblastic leukemia/lymphoma (acute
lymphoblastic leukemia/lymphoblastic lymphoma), acute leukemias of ambiguous lineage …
lymphoblastic leukemia/lymphoblastic lymphoma), acute leukemias of ambiguous lineage …
Mantle cell lymphoma
CY Cheah, JF Seymour, ML Wang - Journal of clinical oncology, 2016 - ascopubs.org
Mantle cell lymphoma (MCL) is an uncommon subtype of non-Hodgkin lymphoma
previously considered to have a poor prognosis. Large gains were made in the first decade …
previously considered to have a poor prognosis. Large gains were made in the first decade …
[HTML][HTML] Primary gastrointestinal lymphoma
P Ghimire, GY Wu, L Zhu - World journal of gastroenterology: WJG, 2011 - ncbi.nlm.nih.gov
Gastrointestinal tract is the most common extranodal site involved by lymphoma with the
majority being non-Hodgkin type. Although lymphoma can involve any part of the …
majority being non-Hodgkin type. Although lymphoma can involve any part of the …
[HTML][HTML] CAR T-Cell therapy for the management of mantle cell lymphoma
Z Huang, VP Chavda, R Bezbaruah, H Dhamne… - Molecular Cancer, 2023 - Springer
Mantle cell lymphoma (MCL) is a subtype of Non-Hodgkin lymphoma (NHL) of mature B-
cells characterized by translocation, which is typically due to excess expression of Cyclin …
cells characterized by translocation, which is typically due to excess expression of Cyclin …
[HTML][HTML] ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma
To complement the existing treatment guidelines for all tumour types, ESMO organizes
consensus conferences to focus on specific issues in each type of tumour. In this setting, a …
consensus conferences to focus on specific issues in each type of tumour. In this setting, a …
[HTML][HTML] SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype
A Mozos, C Royo, E Hartmann, D De Jong, C Baró… - …, 2009 - ncbi.nlm.nih.gov
Background Cyclin D1-negative mantle cell lymphoma is difficult to distinguish from other
small B-cell lymphomas. The clinical and pathological characteristics of patients with this …
small B-cell lymphomas. The clinical and pathological characteristics of patients with this …